ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664271 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664271; 2) Community: the network communities that were significantly associated with the response to NSC 664271; 3) Molecule: the relationships between components within communities and NSC 664271; 4) MDR: the compounds that were significantly associated with the NSC 664271.

NSC Compound Enrichment Correlation
NSC 683782 Null 0.000455867606843419 0.61767992
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.000644707050512996 0.8259625
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.000644707050512996 0.7846782
NSC 626162 Discorhabdin C . TFA 0.000644707050512996 0.83256377
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.000644707050512996 0.83328287
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.000644707050512996 0.78258995
NSC 661832 Null 0.000644707050512996 0.39090751
NSC 681279 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) 0.000644707050512996 0.67509063
NSC 696921 Null 0.000837923650101964 0.68402892
NSC 719468 Null 0.000837923650101964 0.42280428
Total:90  Current:5    [First] [Prev] [Next] [Last]